Leaderboard Ad

Treating Larynx Cancer

Stephen Y. Kang, MD

Larynx Cancer: Updates for the General Otolaryngologist
8:45 am, Today
Room 292

How to treat advanced laryngeal cancers can be controversial, as treatment can be performed using surgical and nonsurgical approaches.

“Determining the ideal treatment modality each individual patient should receive is fairly complex,” said Stephen Y. Kang, MD, with Ohio State University, who is the lead presenter of today’s session.

Dr. Kang and his co-presenter, Theodoros N. Teknos, MD, with Seidman Cancer Center, will review multidisciplinary treatment paradigms for patients with laryngeal cancer and landmark articles that have set the foundation for organ preservation treatment as well as those studies that have shown a benefit for patients treated with primary surgery, he said.

“We’ll also discuss cases that highlight the pros and cons of each approach. The goal is that attendees will walk away from the session with improved ability to counsel newly diagnosed patients with laryngeal cancer,” Dr. Kang said.

Some of the landmark organ preservation trials, such as the Department of Veterans Affairs’ larynx trial, were published in the early 1990s, before some current trainees were even born.

“We still quote these trials, so we believe it’s critical to know these data thoroughly,” he said. “As we are often the first to evaluate these patients, surgeons should understand when to recommend non-surgical treatment and when primary surgical treatment is the best option. If we understand the data, patients will better understand it as well.”

Dr. Kang said he was surprised that patients with T4 laryngeal cancer who have been treated with a primary surgical approach can have excellent survival and functional outcomes with modern reconstruction and speech rehabilitation.

Patients with advanced laryngeal cancer face a challenging decision between total laryngectomy and organ preservation non-surgical treatment, he said.

“We’ll illustrate the nuances in this decision-making paradigm,” Dr. Kang said.

The presenters also will cover optimal airway management of patients with advanced laryngeal cancer.